MyFinsight
Home
Blog
About
Contact
Download
Download image
Unrealized gain on
marketable securities
$44,000
Comprehensive loss
-$74,836,000
Total other
comprehensive gain
$44,000
Net loss
-$74,880,000
Other income, net
$9,889,000
Loss from operations
-$84,769,000
Total operating
expenses
$84,769,000
Research and development
$56,103,000
General and
administrative
$28,666,000
Back
Back
Income Statement
source: myfinsight.com
Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics, Inc. (FULC)